INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 78 filers reported holding INOZYME PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $394,779 | -19.7% | 93,995 | +6.5% | 0.00% | – |
Q2 2023 | $491,591 | +418.4% | 88,257 | +433.3% | 0.00% | – |
Q1 2023 | $94,826 | +445.7% | 16,549 | 0.0% | 0.00% | – |
Q4 2022 | $17,376 | -61.4% | 16,549 | 0.0% | 0.00% | – |
Q3 2022 | $45,000 | -43.0% | 16,549 | 0.0% | 0.00% | – |
Q2 2022 | $79,000 | -36.8% | 16,549 | -45.7% | 0.00% | – |
Q1 2022 | $125,000 | -49.8% | 30,497 | -16.3% | 0.00% | – |
Q4 2021 | $249,000 | -41.1% | 36,427 | 0.0% | 0.00% | – |
Q3 2021 | $423,000 | -59.9% | 36,427 | -41.2% | 0.00% | – |
Q2 2021 | $1,056,000 | -10.4% | 61,917 | +4.1% | 0.00% | – |
Q1 2021 | $1,179,000 | +16.4% | 59,495 | +21.3% | 0.00% | – |
Q4 2020 | $1,013,000 | -20.3% | 49,045 | +1.5% | 0.00% | -100.0% |
Q3 2020 | $1,271,000 | – | 48,334 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 1,009,117 | $26,529,000 | 9.44% |
YALE UNIVERSITY | 113,502 | $2,984,000 | 9.13% |
Sofinnova Investments, Inc. | 2,028,308 | $53,324,000 | 3.95% |
Novo Holdings A/S | 2,569,379 | $67,549,000 | 3.35% |
NEA Management Company, LLC | 2,444,379 | $64,263,000 | 2.72% |
RA Capital Management | 2,003,653 | $52,676,000 | 0.96% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,150,299 | $30,241,000 | 0.74% |
Rock Springs Capital Management LP | 879,954 | $23,134,000 | 0.59% |
SPHERA FUNDS MANAGEMENT LTD. | 196,411 | $5,164,000 | 0.51% |
Orbimed Advisors | 400,400 | $10,527,000 | 0.13% |